Events

Versaport Bladeless Optical 5mm Trocar with Fixation Cannula (Abdominal and thoracic trocar) 의 리콜

Department of Health, Therapeutic Goods Administration에 따르면, 해당 리콜 는 Australia 에서 Covidien Pty Ltd 에 의해 제조된 제품과 관련되어 있습니다.

이것은 무엇인가요?

의료기기에 문제가 생겼을 경우 제조사가 이를 바로잡거나 시장에서 회수하는 조치를 말한다. 회수(Recall)는 의료기기에 결함이 있거나, 건강에 위협이 되거나, 또는 결함도 있고 건강에도 위협이 될 경우에 발생한다.

데이터에 대해 더 자세히 알아보기 여기
  • 사례 유형
    Recall
  • 사례 ID
    RC-2013-RN-00414-1
  • 사례 위험등급
    Class II
  • 사례 시작날짜
    2013-05-10
  • 사례 국가
    Australia
  • 사례 출처
    DHTGA
  • 사례 출처 URL
    https://apps.tga.gov.au/Prod/sara/arn-detail.aspx?k=RC-2013-RN-00414-1
  • 비고 / 경고
    Australian data is current through July 2018. All of the data comes from the Australian Therapeutic Goods Administration, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Australia.
  • 데이터 추가 비고
  • 원인
    Covidien has received reports of seals disengaging from the cannula which may result in a component inadvertently disengaging into the patient's abdominal and thoracic cavity.
  • 조치
    Covidien is asking customers to quarantine and discontinue use of all affected lot numbers. Covidien will arrange for pick-up of the affected lots.

Device

Versaport Bladeless Optical 5mm Trocar with Fixation Cannula (Abdominal and thoracic trocar)
  • 모델명 / 제조번호(시리얼번호)
    Versaport Bladeless Optical 5mm Trocar with Fixation Cannula (Abdominal and thoracic trocar)Multiple product codes and lot numbers:ONB5LGF (Lots N2K0019X through N3A0294X)ONB5SHF (Lots N2J0265X through N3A0391X)ONB5STF (Lots N2H0353X through N3D0033X)ONB5STF2C (Lots N2J0211X through N3D0118X)ONBFCA5SH (Lots N2J0315X through N3A0389X)ONBFCA5ST (Lots N2J0150X through N3C0683X)ARTG Number: 178557
  • Manufacturer
    Covidien Pty Ltd

Manufacturer

Covidien Pty Ltd
  • 제조사 모회사 (2017)
    Medtronic plc
  • 제조사 의견
    “If our surveillance systems identify a potential performance issue, our personnel promptly evaluate the problem, including, when appropriate, conducting root cause investigations and internal testing to assess whether the product continues to meet specifications and defined performance criteria,” Medtronic told ICIJ in a statement. “In some cases, based on this evaluation, Medtronic may determine that a recall is necessary.” The company said that it communicates with healthcare providers and/or patients and provide recommendations to address such issues. Medtronic noted that these communications can include letters, emails, calls, press releases, physician notifications and social media postings, as well as informing the FDA and other regulators of the actions.
  • Source
    DHTGA